Dual inhibition of sphingosine kinase isoforms ablates TNF-induced drug resistance

Por ANTOON, JAMES W., WHITE, MARTIN D., BUROW, MATTHEW E., BECKMAN, BARBARA S.
Publicado em 2012

Dissociation between long-lasting behavioral sensitization to amphetamine and impulsive choice in rats performing a delay-discounting task

Por Stanis, Jessica J., Avila, Hector Marquez, White, Martin D., Gulley, Joshua M.
Publicado em 2008

Sphingosine Kinase Isoforms as a Therapeutic Target in Endocrine Therapy Resistant Luminal and Basal-A Breast Cancer

Por Antoon, James W., White, Martin D., Driver, Jennifer L., Burow, Matthew E., Beckman, Barbara S.
Publicado em 2012

Targeting NFκB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2

Por Antoon, James W, White, Martin D, Slaughter, Evelyn M, Driver, Jennifer L, Khalili, Hafez S, Elliott, Steven, Smith, Charles D, Burow, Matthew E, Beckman, Barbara S
Publicado em 2011

Antiestrogenic Effects of the Novel Sphingosine Kinase-2 Inhibitor ABC294640

Por Antoon, James W., White, Martin D., Meacham, William D., Slaughter, Evelyn M., Muir, Shannon E., Elliott, Steven, Rhodes, Lyndsay V., Ashe, Hasina B., Wiese, Thomas E., Smith, Charles D., Burow, Matthew E., Beckman, Barbara S.
Publicado em 2010